PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection

Dhody, K; Pourhassan, N; Kazempour, K; Green, D; Badri, S; Mekonnen, H; Burger, D; Maddon, PJ

Burger, D (reprint author), CytoDyn Inc, Vancouver, WA 98660 USA.

HIV CLINICAL TRIALS, 2018; 19 (3): 85

Abstract

Background: PRO 140 is a humanized monoclonal antibody targeting CCR5 with potent antiviral activity in patients with CCR5-tropic HIV-1 infection. In ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索